Cargando…

The Combination Therapy of Fluorouracil and Oxaliplatin Suppress the Progression of Colon Cancer Through miR-183-5p/SOCS3 Axis and Downregulating PD-L1

PURPOSE: The purpose of this study was to investigate the mechanism of combination of fluorouracil (FU) and oxaliplatin (OXA) on the progression of colon cancer via miR-183-5p/SOCS3 axis and regulating PD-L1. METHODS: HCT116 cells were treated with 4 μM OXA and 10.5 μM FU, or exogenous regulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Changling, Wang, Yufeng, Cheng, Xianshuo, Zhu, Ying, Yuan, Wenli, Dong, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920511/ https://www.ncbi.nlm.nih.gov/pubmed/33658858 http://dx.doi.org/10.2147/CMAR.S281925

Ejemplares similares

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluorouracil and gemcitabine
por: Yang, Xiaoping, et al.
Publicado: (2019)

Downregulated Circular RNA hsa_circ_0000291 Suppresses Migration And Proliferation Of Gastric Cancer Via Targeting The miR-183/ITGB1 Axis
por: Cao, Chuanwu, et al.
Publicado: (2019)

Type B lactic acidosis from fluorouracil in fluorouracil, oxaliplatin and leucovorin treatment for carcinoma of the colon in a hemodialysis patient
por: Yeung, Emily K, et al.
Publicado: (2018)

Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells
por: Attoub, Samir, et al.
Publicado: (2018)

Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice
por: Yip, Kwan-Ling, et al.
Publicado: (2022)

MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN
por: Xue, Xinying, et al.
Publicado: (2016)

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
por: Fischel, J-L, et al.
Publicado: (2001)

Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment
por: Negrei, Carolina, et al.
Publicado: (2016)

Fluorouracil/oxaliplatin: Coronary vasospasm and neutropenia: case report
Publicado: (2019)

Fluorouracil/oxaliplatin/panitumumab: Lack of efficacy: case report
Publicado: (2022)

Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy
por: Ihoriya, Hiromi, et al.
Publicado: (2018)

Mutational Pattern Induced by 5-Fluorouracil and Oxaliplatin in the Gut Microbiome
por: Wan, Li, et al.
Publicado: (2022)

Downregulation of miR-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis
por: SHI, XIAO-YAN, et al.
Publicado: (2014)

LEMD1-AS1 Suppresses Ovarian Cancer Progression Through Regulating miR-183-5p/TP53 Axis
por: Guo, Ruowen, et al.
Publicado: (2020)

The Impact of Nrf2 Silencing on Nrf2-PD-L1 Axis to Overcome Oxaliplatin Resistance and Migration in Colon Cancer Cells
por: Payandeh, Zahra, et al.
Publicado: (2021)

Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer
por: Kim, Jong-Hwan, et al.
Publicado: (2018)

Suppression of T-Cell Proliferation by Normal Density Granulocytes Led to CD183 Downregulation and Cytokine Inhibition in T-Cells
por: Westerlund, Julia, et al.
Publicado: (2022)

Effects of valproic acid on SOCS-1, SOCS-2, SOCS-3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2022)

Circ_0003356 suppresses gastric cancer growth through targeting the miR-668-3p/SOCS3 axis
por: Li, Wei-Dong, et al.
Publicado: (2023)

The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183
por: Sun, Jian, et al.
Publicado: (2019)

Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients
por: Dai, Xichao, et al.
Publicado: (2016)

LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis
por: Zhou, Yongping, et al.
Publicado: (2021)

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001)

The Effect of Compound Sophora on Fluorouracil and Oxaliplatin Resistance in Colorectal Cancer Cells
por: Yin, WeiHua, et al.
Publicado: (2019)

Fluorouracil/folinic acid/oxaliplatin: Various toxicities: 2 case reports
Publicado: (2021)

miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn’s disease
por: Cheng, Xiuqin, et al.
Publicado: (2015)

miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia
por: Navarro, A, et al.
Publicado: (2016)

miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells
por: ZHAO, HAIEN, et al.
Publicado: (2012)

Suppression of GRP78 sensitizes human colorectal cancer cells to oxaliplatin by downregulation of CD24
por: Xi, Jingle, et al.
Publicado: (2018)

Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
por: Zhao, Yang, et al.
Publicado: (2021)

Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1
por: Renrick, Ariana N., et al.
Publicado: (2021)

MiR-218-5p-dependent SOCS3 downregulation increases osteoblast differentiation inpostmenopausal osteoporosis
por: Zhou, Qian, et al.
Publicado: (2023)

Curcumin Enhances the Effects of 5-Fluorouracil and Oxaliplatin in Inducing Gastric Cancer Cell Apoptosis Both In Vitro and In Vivo
por: Zhou, Xiang, et al.
Publicado: (2016)

Adjuvant 5‐Fluorouracil/leucovorin, capecitabine, and oxaliplatin‐related regimens for stage II/III colon cancer patients 66 years or older
por: Jones, Emily, et al.
Publicado: (2022)

Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2018)

MiR-183-5p Induced by Saturated Fatty Acids Hinders Insulin Signaling by Downregulating IRS-1 in Hepatocytes
por: Nguyen, Mai Thi, et al.
Publicado: (2022)

circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis
por: Xu, Jian-Zhen, et al.
Publicado: (2019)

Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
por: Yang, Chun, et al.
Publicado: (2019)

Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin
por: Cui, Wei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ujqa6i1j5lnfs9mog9peuik0vb